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ABSTRACT 
 
The thesis entitled “Total Synthesis of Mitochondrial NADH Oxidase Inhibitor 
Circumdatin H, Opium Alkaloid Noscapine and Development of New Methodologies in 
Organic Synthesis” has been divided into three chapters. 
 
Chapter I: First total synthesis of mitochondrial NADH oxidase inhibitor (-)-circumdatin 
H and its novel quinazolinone analogues     
 
Chapter II: Synthetic studies and improved process for the synthesis of opium alkaloid 
noscapine 
 
Chapter III: This chapter is further divided into two sections 
Section A: Synthesis of 2,5-diamino-1,4-benzoquinone 
Section B: Synthesis of anticancer agent (±)-monastrol and its analogues 
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Chapter I  
First total synthesis of mitochondrial NADH oxidase inhibitor (-)-circumdatin H and its 
novel quinazolinone analogues 
Introduction 
     Recently, a new group of qunazolinones fused to benzodiazepines were isolated from 
Aspergillus ochraceus extracts and they exhibited very interesting biological activities such 
as antitumor, antifungal, antibiotic activities. (-)-Circumdatin H 1a (Figure 1), was isolated 
from a fungus culture broth of Aspergillus ochraceus, and it was found to be inhibitor of the 
mammalian mitochondrial integrated electron transfer chain (mitochondrial NADH oxidase 
inhibitor) with IC50 values of 1.5 ± 0.1 µM. The structure of (-)-circumdatin H was 
determined by comparison of its 1H NMR, 13C NMR spectral data and 2D NMR experiments 
with those of other known circumdatins, The stereochemistry at C-19 of 1a was tentatively 
assigned by comparison of the sign of the optical rotation value of 1a with that of other 
circumdatins. 
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     Quinazolinones, 3-(2-carbomethoxyphenyl)-2-methyl-4(3H)-quinazolinone 2 (Figure 1) 
was newly isolated natural product from Aconitum pseudo-laeve var. erectum Nakai 
(Ranunculaceae), and are pharmacologically active as sedative hypnotic drug [methaqualone 
3 (Figure 1)], antitussive (chloroqualone) and anticonvaulsant (piriqualone). In addition, 
quinazolinone derivatives are also possesses antimalarial, antibacterial, antidiabetic and 
anticancer activity.  
Present work 
     In continuation of our ongoing program on synthesis of pyrrolobenzodiazepines as 
cytotoxic agents, now we have focused our attention on total synthesis of benzodiazepine 
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fused biologically active natural products. In this connection, we have undertaken the 
synthesis of (-)-circumdatin H and its analogue for studying structure activity relationship. 
We report the first total synthesis of mitochondrial NADH oxidase inhibitor (S)-(-)-
circumdatin H and its analogue by chiron approach and unambiguously assigned and confirm 
the absolute configuration of natural (S)-(-)-circumdatin H as 19(S). We also report a new 
method utilized for the synthesis of 3-(2-carbomethoxyphenyl)-2-methyl-4(3H)-
quinazolinone, methaqualone and their novel analogues. 
Figure 2: Retro synthetic analysis of circumdatin H and its analogue 
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     Retro synthetic analysis of (-)-circumdatin H revealed two possible synthetic strategies, 
one is path-A; and another one is path-B (Figure 2).  
Synthesis of circumdatin H analogue via quinazolinone intermediate (path-A): 
     Synthesis of circumdatin H analogue initially started from the commercially available 
anthranilic acid and L-proline [(S)-pyrrolidin-2-carboxylic acid]. Methylanthranilate 13a was 
prepared quantitatively by methylation of anthranilic acid with dimethyl sulfate. N-Boc-L-
proline 9 was prepared from L-proline and di-tert-butyl dicarbonate. Amide 14 was prepared 
by the condensation reaction of methylanthranilate 13a with N-Boc-L-proline 9 under 
essential neutral conditions by using HOBt, and DCC in dry THF in 73% yield. Compound 
14 was subjected to hydrolysis with 10% aqueous LiOH solution in a (2:1) mixture of MeOH 
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and THF for over night afforded benzoic acid 15 in 94% yield. Cyclization of compound 15 
to 2-(N-tert.butyloxycarbonyl)-L-prolinyl-amino)-benzo[d][1,3]oxazin-4-one 5 was achieved 
in 95% yield, in the presence of N,N’-carbonyldiimidazole (CDI) in dry THF at room 
temperature for 1 h (Scheme 1).        
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     Cyclocondensation reaction of compound 5 with methyl anthranilate 13a in refluxing 
pyridine, or in the presence of ZnCl2 resulted, complex mixture of carbonaceous compounds. 
Where as the cyclocondensation reaction of 2-methyl-benzo[d][1,3]oxazin-4-one 17a with o-
toluidine 13b in pyridine at 150 °C for 3 h afforded the desired product 3 in 13% yield.  
     Tetra-n-butylammonium bromide (TBAB) is an inexpensive readily available ionic liquid 
has been used as homogeneous catalyst in various organic transformations, and in view of its 
inherent properties like environmental compatibility, operational simplicity, non corrosive 
nature; we have used TBAB for the first time in the cyclocondensation reaction of various 
benzoxazin-4-ones with amines.       
Scheme 2 
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     2-Methyl-benzo[d][1,3]oxazin-4-one 17a was prepared from anthranilic acid by reaction 
with acetic anhydride at reflux temperature, and it was used immediately in the next step. 
Cyclocondensation reaction of freshly prepared 17a with equivimolar amounts of o-toluidine 
13b and TBAB at 120 °C under N2-atm. the reaction was completed within 60 minutes and 
resulted expected product methaqualone 3 in 83% yield (Scheme 2).   
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    We attempted the synthesis of newly isolated quinazolinone alkaloid 2. Compound 17a 
upon reaction with equimolar amount of methylanthranilate 13a in the presence of TBAB at 
120 °C under N2-atm. for 60 minutes, after completion of reaction the reaction mixture was 
diluted with ethyl acetate, extracted with 2% aq. NaHCO3 solution and the organic layer was 
purified by silica-gel column chromatography to give 2 in 69% yield (over two steps) as a 
pale yellow solid (Scheme 3).  
Scheme 3 
N
O
O
N
N
O
CO2CH3
     TBAB, 
120 0C, 60 min.
17a 2
H2N
CO2CH3
13a
+
 
     2-Methyl-bnezo[d][1,3]oxazin-4-ones 17a-d were prepared from corresponding 
anthranilic acids 16a-d by the reaction with acetic anhydride at reflux temperature. The 
amines; o-toluidine 13b, (R)-(+)-1-phenylethylamine 13d were readily available where as 
methylanthranilate 13a was prepared by esterification of anthranilic acid, and 3,4-
dimethoxyphenethylamine 13c was prepared from veratraldehyde.  
Scheme 4 
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     Veratraldehyde 18 upon reaction with nitromethane and piperidine acetate (Henry 
reaction) in benzene afforded β-nitrostyrene 19 in 72% yield, followed by reduction with 
LAH in THF afforded 3,4-dimethoxyphenethylamine 13c in 52% yield (Scheme 4). 
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     Anthranilic acids 16b and 16c are prepared from vanillic acid as below; compound 22 was 
prepared from vanillic acid 20 by methylation followed by nitration. Base hydrolysis of ester 
22 using 10% aqueous NaOH solution in 1:1 mixture of water and 1,4-dixane afforded 
nitrobenzoic acid 23 in 96% yield. Compound 23 upon reduction using H2-Pd/C (5%) at 1 
atm. pressure in methanol at room temperature resulted 2-amino-4,5-dimethoxybenzoic acid 
16b in 88% yield (Scheme 5). 
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     Methyl vanillate 24 was prepared from vanillic acid 20 by esterification using methanol 
and catalytic amount of sulfuric acid in 94% yield. Ester 24 upon reaction with propargyl 
bromide using K2CO3 in acetone afforded ether 25 in 81% yield. Ether 25 upon 
regioselective nitration using 70% HNO3 resulted nitro compound 26 in 70% yield. 
Compound 26 upon ester hydrolysis using 10% NaOH solution in water in a 1:1 mixture of 
1,4-dioxane and water afforded acid 27 in 94% yield. Compound 27 upon reduction using 
iron in acetic acid afforded compound 16c in 43% yield (Scheme 6).  
     To study the feasibility and applicability of this reaction process we have prepared various 
2,3-disubstituted quinazolin-4-ones 28a-h by the cyclocondensation reaction of  4H-3,1-
benzoxazin-4-ones 17a-d and amines 13a-d using TBAB at 120 °C (Scheme 7). 
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                  28a: R’=R’’=R’’’=H; R= (R)-(+)-1-phenylethylamine 
                  28b: R’=R’’=R’’’=H; R= 3,4-dimethoxyphenethylamine 
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                  28c: R’=Cl; R’’=R’’’=H; R= (R)-(+)-1-phenylethylamine 
                  28d: R’=OCH3; R’’=OCH3; R’’’=H; R= o-toluidine  
                  28e: R’=OCH3; R’’=OCH3; R’’’=H; R= (R)-(+)-1-phenylethylamine 
                  28f: R’=OCH3; R’’=OCH3; R’’’=H; R= 3,4-dimethoxyphenethylamine 
                  28g: R’=OCH3; R’’=OCH2CCH; R’’’=H; R= o-toluidine 
                  28h: R’=OCH3; R’’=OCH2CCH; R’’’=H; R= 3,4-dimethoxyphenethylamine 
     The success of the synthesis of compound 2, 3 and various 2,3-disubstituted-3H-
quinazolin-4-ones 28a-h mediated by TBAB encouraged us to pursue the synthesis of 
circumdatin H analogue. Freshly prepared benzo[d][1,3]oxazin-4-one 5 upon reaction with 
equimolar amount of methylanthranilate 13a using TBAB under N2-atm. at 120-160 °C for 6 
h resulted (±)-circumdatin H analogue 29 in 52% yield, and a homo-coupled byproduct dione 
30 in 12% yield (Scheme 8).  
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     During the course of reaction enantiomeric erosion was encountered and resulted (±)-
circumdatin H analogue 29 in racemic form. To overcome the racemization, we switched 
over to another route. Alternatively, we have followed another approach of path-A starting 
from anthranilic acid for the synthesis of circumdatin H analogue via quinazolinone 
intermediate route. 
     Compound 8 was prepared from anthranilic acid 16a by the reaction with thionyl chloride 
followed by methylanthranilate 13a in 46% yield. Compound 8 upon condensation reaction 
with N-Boc-L-proline 9, DCC and HOBt in dry THF afforded the triamide 7 in 57% yield. 
Compound 7 was treated with 3 equiv. of HMDS and four equiv. of I2 in DCM at room 
temperature for 48 h, then the reaction mixture was washed with 5% Na2S2O3.5H2O solution 
in water and the resulting reaction mixture was purified by silica gel column chromatography 
resulted only in the isolation of Boc-deprotected 2-[2-(L-prolinyl)-benzoylamino]-benzoic 
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acid methyl ester 32 as sole product instead of expected quinazolinone compound 4 (Scheme 
9). We felt the need to develop an alternate route for the synthesis of circumdatin H. 
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CO2H
NH2 N
Cl
O
S O
CO2CH3
NH2
NH2
N
H
O
CO2CH3
HN
N
H
O
CO2CH3O
HN
H
HN
N
H
O
CO2CH3O
N
H
Boc
N
N
O
CO2CH3
NBoc
H
SOCl2
toluene, reflux
13a
toluene, r.t., 48 h
N
H
CO2H
Boc
DCC, HOBt, THF,
0 0C - r.t.
HMDS, I2
CH2Cl2, r.t.
×
16a 31 8
9
7 4
32
 
Synthesis of (-)-circumdatin H and its analogue via Eguchi aza-Wittig protocol (path-
B): 
Scheme 10 
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     First, we planned to synthesize (-)-circumdatin H analogue 1b starting from the 
anthranilic acid 16a and chiral starting material L-proline 34. Isatoic anhydride 33 was 
prepared from anthranilic acid using ethyl chloroformate and triethylamine. Dione 11 was 
prepared from the reaction of isatoic anhydride 33 with L-proline 34 in DMSO in 82% yield 
(Scheme 10).  
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     Anthranilic acid 16a upon diazotization using aqueous NaNO2, followed by nucleophilic 
substitution of azide using NaN3 resulted 2-azido benzoic acid 35 in 77% yield (Scheme 11). 
Compound 35 was converted into 2-azido-benzoyl chloride 12b by the reaction of thionyl 
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chloride resulted 12b, and it was immediately used in the next step. Dione 11 in dry THF was 
acylated with freshly prepared 2-azidobenzoyl chloride 12b using triethylamine and DMAP 
at 20 °C under N2-atm. gave crude 10b as brownish syrup, which was used immediately for 
the next step (Scheme 12). 
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     The azide derivative 10b was treated with tributylphosphine at 60 °C in dry benzene 
under N2-atm. afforded (S)-(-)-circumdatin H analogue 1b in 63% yield over two steps 
(Scheme 12). Compound 1b exhibited a specific rotation of -128.60° (c 0.5, MeOH).  
     2-Amino-5-methoxybenzoic acid 16e in a solution of aq. 25% HCl was diazotized with 
NaNO2, and the resulted reaction mixture was treated with sodium azide afforded pure 2-
azido-5-methoxy-benzoic acid 36 in 95% yield.  
Scheme 13 
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     Compound 36 upon treatment with thionyl chloride resulted benzoyl chloride 12a, and it 
was used immediately in the next step. Dione 11 was acylated with compound 12a in dry 
THF using triethylamine and DMAP at 20 °C under N2-atm. afforded crude 10a, which was 
used immediately in the next step. Crude compound 10a in dry benzene was treated with (n-
Bu)3P at 60 °C under N2-atm. afforded (-)-circumdatin H 1a in 73% yield (35.03% overall 
yield starting from anthranilic acid over four steps) (Scheme 14). (-)-Circumdatin H was fully 
characterized by the analysis 1H NMR, 13C NMR and DEPT, IR, HR-MS spectral data, and 
they are identical with the authentic data. 
 
 10 
Scheme 14 
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     We assigned the stereochemistry of natural and synthetic (-)-circumdatin H at C-19 as C-
19(S) without ambiguity by synthesis of (-)-circumdatin H starting from S-proline, and based 
on sign of optical rotation of natural and synthetic (-)-circumdatin H 1a [α]D -130.77 (c 
0.078, MeOH), and its analogue 1b [α]D -128.60 (c 0.5, MeOH). 
Chapter II 
Synthetic studies and improved process for the synthesis of opium alkaloid noscapine 
Introduction 
     Noscapine 37 is a naturally occurring phthalideisoquinoline alkaloid obtained from 
opium. It has been used orally in humans as an antitussive drug. Noscapine inhibits the 
progression of murine lymphoma, melanoma, and human breast tumors implanted in nude 
mice with little or no toxicity to the kidney, heart, liver, bone-marrow, spleen, or small 
intestine and does not inhibit primary humoral immune responses in mice.  
Figure 3 
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37: (-)-α-(1R, 9S)-Noscapine  
     However, noscapine is available from natural source, in view of environmental issues and 
the increasing demand for noscapine, we felt the need to develop a synthetic route and 
process development is essential for the synthesis of noscapine. Herein, we report a synthetic 
process for the synthesis of noscapine at multigram scale by zinc-promoted reductive 
coupling reaction of cotarnine iodide 41 with 3-bromomeconine 48 as the key step. 
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Present work 
     In continuation of our program on the synthesis of biologically active natural products, we 
undertook the synthesis and process development of an antitussive drug and anticancer agent 
of opium alkaloid noscapine. Synthesis of noscapine was achieved in three different methods 
(method A-C), and method-C was developed into multigram scale level. 
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     Initially, for our synthetic experiments cotarnine 38 was prepared from (-)-α-noscapine 37 
by oxidative degradation with 18% nitric acid in 96% yield, and  opianic acid 39 in 89% 
yield.  
Method A: 
Scheme 16 
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     In this method, meconine 40 was prepared from opianic acid 39 by the reaction with 
NaBH4 in EtOH in 74% yield (Scheme 16).  
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     A solution of cotarnine 38 and meconine 40 in ethanol was refluxed for 4 h then the crude 
product was purified by silica gel column chromatography afforded (±)-α/β-noscapine 37a/b 
in 0.25% yield (Scheme 17). 
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Method B: 
     In this method, for the conversion of cotarnine 38 to cotarnine iodide 41, we have 
developed a novel method without using any organic solvents, indeed in water. Cotarnine 38 
was dissolved in equimolar amount of aq. 1N HCl, and was treated with two equivalents of 
potassium iodide gave cotarnine iodide 41 in 93% yield (HPLC 98% pure). 
Scheme 18 
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     Meconine 40 upon treatment with LDA followed by cotarnine iodide 41 in THF at – 70 
°C for 18 h, and the reaction mixture was purified by silica gel column chromatography 
afforded (±)-α/β-noscapine 37a/b in 2.3% yield (Scheme 19) . 
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Due to the low yield and the cost of reagents, we have switched over to the alternate method. 
Method-C: 
     In this method, meconine 40 was prepared from 2,3-dimethoxybenzoic acid 43, using 
conc. HCl and 37% aqueous formaldehyde solution at 95 °C for 20 minutes. Then the 
reaction mixture was cooled to 10 °C and the separated solid was filtered to give over 
alkylated byproduct 44 in 12% yield. The filtrate was diluted with ice cold water afforded a 
crude product of meconine 40 and recrystallized from water gave pure meconine 40 in 33% 
yield (HPLC 97% pure) (Scheme 20). 
Scheme 20 
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     During the recrystallization of crude meconine in water, the byproduct 44 was converted 
into an alcohol 45. Formation of alcohol 45 from byproduct 44 was confirmed by converting 
the byproduct 44 into alcohol 45 by boiling the compound 44 in water for 30 minutes. 
Scheme 21 
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     Alcohol 45 was acetylated using Ac2O/pyridine at room temperature resulted, acetyl 
derivative 46.  
Scheme 22 
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     Meconine 40 upon bromination with NBS in CCl4 using catalytic amount of benzoyl 
peroxide at reflux temperature for 6.5 h, resulted 3-bromomeconine 48 (>99% pure by 1H 
NMR) in 99% yield (Scheme 22). Formation of 4-bromomeconine 49 was excluded by 
performing the bromination reaction under neutral conditions.      
     To a solution of cotarnine iodide 41 and 3-bromomeconine 48 in CH3CN under N2-atm 
was added zinc dust and stirred at -10 °C to 0 °C for 2 h and at room temperature for 26 h. 
After completion of reaction, solvent was removed, diluted with DCM and was treated with 
10% aqueous NaHCO3 and the insoluble solid was filtered. From the filtrate, organic layer 
was separated and concentrated to give crude (±)-α/β-noscapine 37a/b. 
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Scheme 23 
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     The crude (±)-α/β-noscapine 37a/b was boiled with methanol and insoluble solid was 
filtered to afford a solid of 1st crop. Methanolic mother liquor was cooled to room 
temperature for 2 h; separated solid was filtered to give 2nd crop solid. After removal of 2nd 
crop, the resulted methanolic mother liquor was kept at 20 °C for 48 h and the separated solid 
was filtered to give 3rd crop solid (Scheme 23).  
     The solid of 1st crop was dissolved in aqueous solution of 1N HCl at room temperature, 
insoluble material was filter off, which was characterized as a dimer of meconine 51. The 
acidic filtrate was basified with an aqueous solution of 12.5% NH3 at 10 °C, resulted 
precipitate was filtered to give pure (±)-α-noscapine 37a in 56% of isolated yield (HPLC 
>99% pure; chiral HPLC shown the presence of (-)-α-noscapine and (+)-α-noscapine in 1:1 
ratio). The overall yield of (±)-α-noscapine 37a starting from meconine over two steps was 
55% or starting from cotarnine over two steps was 52%. 
     The 3rd crop was purified (as 1st crop) by acid base treatment to give pure (±)-β-noscapine 
37b in 31% of isolated yield (HPLC >99% pure; chiral HPLC shown the presence of (-)-β-
noscapine and (+)-β-noscapine in 1:1 ratio). The overall yield of (±)-β-noscapine 37b starting 
from meconine over two steps was 30% or starting from cotarnine over two steps was 29%. 
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     Attempts were made to get the diastereoselectivity under developed coupling reaction 
conditions using 10 mol% of chiral auxiliary. Use of dihydrocinchonine, (-)-sparteine, or L-
prolinol as chiral auxiliaries could not succeed in achieving required diastereoselectivity. 
     Resolution of (±)-α-noscapine 37a into (-)-(1R, 9S)-α-noscapine  and its enantiomer of 
(+)-(1S, 9R)-α-noscapine was attempted using various chiral acid resolving agents including 
L-(+)-tartaric acid, (S)-(+)-mandelic acid, (R)-(+)-4-(2-chlorophenyl)-2-hydroxy-5,5-
dimethyl-1,3,2-dioxaphosphorinane 2-oxide, (R)-(-)-mandelic acid, (1S)-(+)-10-
camphorsulfonic acid, (1S)-(+)-3-bromocamphorsulfonic acid, (1R, 3S)-(+)-camphoric acid, 
D-(+)-malic acid, di-p-toluoyl-D-tartaric acid, cholic acid, L-(-)-3-phenylacetic acid, (1R, 3R, 
4R, 5R)-(-)-quinic acid, naproxen, S-fenavaleric acid were attempted. Most of the chiral acids 
did not formed diastereomeric salt with (±)-α-noscapine 37a. Some of the chiral acids formed 
a protinated salt of (±)-α-noscapine. While some of them formed diastereomeric salt with (±)-
α-noscapine, but they did not crystallized.  
Chapter III: This chapter is further divided into two sections. 
Section A: Synthesis of 2,5-diamino-1,4-benzoquinone. 
Introduction 
     The natural product terreusinone 52 (Figure 5), isolated from the marine algicolous fungus 
Asperigillus terreus, was detected to possess UV-A absorbing activity with an ED50 value of 
70 µg/mL.  
Figure 5 
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     2,5-Diamino-1,4-benzoquinone 53 (Figure 5) is an integral structure of naturally 
occurring biologically active compounds such as terreusinone 52. It is also an integral 
structure of synthetic drug benzoquinonium chloride, a skeletal muscle relaxant drug. It is a 
useful intermediate for the preparation of many industrial dyestuffs. 2,5-Diamino-1,4-
benzoquinone 53 derivatives especially 2,5-aziridinyl-1,4-benzoquinone was found to form 
interstrand crosslink DNA, and it was cytotoxic in vitro. 
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Present Work 
     We attempted the synthesis of terreusinone having a dipyrrolo-1,4-benzoquinone moiety. 
Retro synthetic analysis of terreusinone 52 revealed two fragments; of which one is 2,5-
diamino-1,4-benzoquinone 53 and another one is an aliphatic fragment 54 (Figure 5). The 
present work describes a novel and efficient method for the synthesis of 2,5-diamino-1,4-
benzoquinone 53 based on the hydrogenolysis of 2,5-diamino-3,6-dibromoquinone 58 over 
palladium-on-charcoal. 
     1,4-Benzoquinone 55 was prepared from p-hydroquinone using CrO3 in acetic acid and 
water. Benzoquinone 55 upon bromination in acetic acid gave tetrabromo-1,4-hydroquinone 
56 (bromanillic acid) in 85% yield. Bromanillic acid 56 upon oxidation using CrO3 in acetic 
acid afforded tetrabromo-1,4-benzoquinone 57 (bromanil) in 95% yield. Bromanil 57 upon 
treatment with ammonia in ethanol at reflux temperature for 8 h, gave 2,5-diamino-3,6-
dibromoquinone 58 in 74% yield (Scheme 24). 
Scheme 24 
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     Hydrogenolysis of 2,5-diamino-3,6-dibromoquinone 58 with catalytic amounts of 5% 
palladium on charcoal at 45 psi in methanol at ambient temperature. Subsequent base 
hydrolysis with triethylamine in methanol-water (1:1) resulted in the formation of 2,5-
diamino-1,4-benzoquinone 53 as bright reddish-brown crystalline solid in 82% yield; and the 
overall yield was 48.99% starting from benzoquinone 55 in four steps (Scheme 24). 
(Synthesis 2007, 187-189). 
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Section B: Synthesis of anticancer agent (±)-monastrol and its analogues 
Introduction: 
     In recent years 3,4-dihydropyrimidin-2(1H)-ones 59 (DHPMs) scaffolds displays a 
fascinating array of pharmacological and therapeutic properties such as antibacterial, 
antihypertensive and neuropeptide (NPY) antagonists. 4-(3-Hydroxyphenyl)-2-thione 
derivative (±)-monastrol 59g was found to possess mitotic kinesin Eg5 inhibitor acitivity. 
Figure 6 
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Present work 
     Due to our interest on synthesis of biologically active compounds, we targeted the 
synthesis of anticancer agent (±)-monastrol 59g (Figure 6) and its analogues for studying 
structure activity relation ship. Use of potassium dodecatungstocobaltate trihydrate 
(K5CoW12O40.3H2O) an environmentally benign, reusable heteropoly acid catalyst for a wide 
variety of organic transformations by our group as well as others, prompted us to explore the 
potential of K5CoW12O40.3H2O as catalyst for one-pot three component 
heterocyclocondensation process.  We report the synthesis of Biginelli compounds by the 
one-pot three-component condensation of aryl aldehyde, alkyl acetoacetate and urea or 
thiourea promoted by K5CoW12O40.3H2O (0.01 equiv. or 1.0 mol%) under solvent-free 
conditions at 80 °C in excellent yields (Scheme 25). 
Scheme 25 
N
H
NH
R'
R''O
O
X
R
R H
O
R' OR''
O O
H2N NH2
X
K5CoW12O40.3H2O (1.0 mol%),
80 0C, 30-90 min
+ +
60a-m 61a-d 62a; X=O
62b; X=S 59a-r
      
     In a typical experimental procedure, a mixture of aldehyde 60, β-keto ester 61, urea 62 
and K5CoW12O40.3H2O (1 mol%, 0.01 equiv.), was heated at 80 °C for appropriate time (30-
 18 
90 minutes). The reaction mixture was poured onto crushed ice and the precipitated solid was 
filtered to give crude product of 59. The crude product 59 was dissolved in boiling EtOH and 
the insoluble catalyst was filtered. Filtrate was cooled to room temperature and the separated 
crystals were filtered to give analytically pure DHPMs 59 in excellent yields (Scheme 25). 
The filtered catalyst was (quantitatively recovered) reactivated by heating the catalyst at 80 
°C for 2 h and it was reused for three times without considerable loss of activity. 
     This method offers several advantages including high yields, short reaction times, and a 
simple work-up procedure; moreover the catalyst was recovered and reused for several times 
without loss of activity. Furthermore, the present procedure is readily amenable to parallel 
synthesis and the generation of combinatorial dihydropyrimidinone libraries. 
Figure 7 
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     Condensation of 2-hydroxybenzaldehyde with ethyl acetoacetate and urea in presence of 
K5CoW12O40.3H2O resulted diazatricyclo compound 59s (Figure 7) in place of expected 
DHPM. Condensation of 4-methoxybenzaldehyde with ethyl trifluoroacetoacetate 61e and 
urea in presence of K5CoW12O40.3H2O resulted hexahydropyrimidine 59t (Figure 7) in place 
of expected DHPM. (Heterocycles 2006, 68, 1217-1224). 
 
 
 
 
 
 
 
 
 
